Market Tracker

09/30 4:23pm ET

Array Biopharma Inc (NASDAQ:ARRY)

6.75
Delayed Data
As of 4:00pm ET
 +0.51 / +8.17%
Today’s Change
2.38
Today|||52-Week Range
7.27
+59.95%
Year-to-Date
5 Top Performing Stocks of the Best ETF of Q3
9:51am / Zacks.com - Paid Partner Content
Futures Swing Into Positive Territory During Debate, Asia Lower
Sep 26 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data
Sep 28 / Zacks.com - Paid Partner Content
Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today
Sep 26 / MotleyFool.com - Paid Partner Content
3 Reasons to Buy Array Biopharma
Sep 27 / MotleyFool.com - Paid Partner Content
Why Array BioPharma Inc Is Surging Today
Sep 26 / MotleyFool.com - Paid Partner Content
Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success
Sep 27 / TheStreet.com - Paid Partner Content
Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target
Sep 26 / TheStreet.com - Paid Partner Content
Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep 27 / Zacks.com - Paid Partner Content
Mid-Morning Market Update: Markets Open Lower; Cal-Maine Posts Wider-Than-Expected Lo...
Sep 26 / Benzinga - Paid Partner Content

Today’s Trading

Previous close6.24
Today’s open6.28
Day’s range6.18 - 6.84
Volume9,641,514
Average volume (3 months)4,251,152
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-4.04%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.33+4.67%
MGNXMacroGenics Inc+0.48+1.63%
XNCRXencor Inc+0.11+0.45%
RGENRepligen Corp+0.65+2.20%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts